Revenue Analysis - AMGN
Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.
AMGN Corporation
Revenue by Product Line
Latest quarterly revenue breakdown by product segments
Quarterly Product Revenue
Product Revenue Details
Detailed breakdown of revenue by product line
Other Products
0.0% of total revenue
$1.7B
Prolia
0.0% of total revenue
$1.1B
Repatha (evolocumab)
0.0% of total revenue
$696.0M
Otezla
0.0% of total revenue
$618.0M
ENBREL
0.0% of total revenue
$604.0M
XGEVA
0.0% of total revenue
$532.0M
EVENITY
0.0% of total revenue
$518.0M
TEPEZZA
0.0% of total revenue
$505.0M
Product and Service, Other
0.0% of total revenue
$408.0M
BLINCYTO
0.0% of total revenue
$384.0M
Kyprolis
0.0% of total revenue
$378.0M
Nplate
0.0% of total revenue
$369.0M
Aranesp
0.0% of total revenue
$359.0M
KRYSTEXXA
0.0% of total revenue
$349.0M
TEZSPIRE
0.0% of total revenue
$342.0M
Vectibix
0.0% of total revenue
$305.0M
Historical Revenue Data
Quarterly product revenue breakdown over time (Last 6 records)
| Date | Aranesp | BLINCYTO | ENBREL | EVENITY | KRYSTEXXA | Kyprolis | Nplate | Otezla | Other Products | Product and Service, Other | Prolia | Repatha (evolocumab) | TEPEZZA | TEZSPIRE | Vectibix | XGEVA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6/30/2025 | $359.0M | $384.0M | $604.0M | $518.0M | $349.0M | $378.0M | $369.0M | $618.0M | $1.7B | $408.0M | $1.1B | $696.0M | $505.0M | $342.0M | $305.0M | $532.0M |
| 3/31/2025 | $340.0M | $370.0M | $510.0M | $442.0M | $236.0M | $324.0M | $313.0M | $437.0M | $1.6B | $276.0M | $1.1B | $656.0M | $381.0M | $285.0M | $267.0M | $566.0M |
| 12/31/2024 | $308.0M | $381.0M | $1.0B | $431.0M | $346.0M | $372.0M | $337.0M | $624.0M | $4.3B | $1.0B | $1.2B | $606.0M | $460.0M | $296.0M | $246.0M | $561.0M |
| 9/30/2024 | $337.0M | $327.0M | $825.0M | $399.0M | $310.0M | $378.0M | $456.0M | $564.0M | $1.4B | $352.0M | $1.0B | $567.0M | $488.0M | $269.0M | $282.0M | $541.0M |
| 6/30/2024 | $348.0M | $264.0M | $909.0M | $391.0M | $294.0M | $377.0M | $346.0M | $544.0M | $1.3B | $347.0M | $1.2B | $532.0M | $479.0M | $234.0M | $270.0M | $562.0M |
| 3/31/2024 | $349.0M | $244.0M | $567.0M | $342.0M | $235.0M | $376.0M | $317.0M | $394.0M | $1.4B | $329.0M | $999.0M | $517.0M | $424.0M | $173.0M | $247.0M | $561.0M |
Revenue Trend Analysis
Analysis of major growing and declining segments based on recent revenue data